ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Nervous System Diseases : Neurodegenerative Diseases


Include trials that are no longer recruiting patients.

128 studies were found. Here are studies 1 to 50.
1.RecruitingCause and Pathogenesis of Neurometabolic Disorders
Condition: Neurodegenerative Disease
2.RecruitingBiological Markers in Parkinson's Disease
Condition: Parkinson Disease
3.RecruitingContinuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
4.RecruitingBiomarkers and Early Alzheimer's Disease
Condition: Alzheimer's Disease
5.RecruitingPredictors of Cognitive Decline in Normal Aging
Conditions: Alzheimer Disease; Dementia
6.RecruitingPET Changes in Alzheimer's Disease (AD)
Condition: Alzheimer Disease
7.RecruitingSGS742 in Patients with Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
8.RecruitingFish Oil and Alpha Lipoic Acid in Treating Alzheimer’s Disease
Conditions: Alzheimer's Disease; Oxidative Stress; Dementia; Hyperlipidemia; Inflammation
9.RecruitingThe Safety and Efficacy of Neramexane in Patients with Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
10.RecruitingRisk Evaluation and Education for Alzheimer’s Disease (REVEAL) II
Condition: Alzheimer Disease
11.RecruitingLisuride Patch to Treat Parkinson's Disease
Condition: Parkinson Disease
12.RecruitingEvaluation of Alzhemed™ in Patients with Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
13.RecruitingEffect of Lithium and Divalproex in Alzheimer's Disease
Condition: Alzheimer Disease
14.RecruitingCERE-110 in Subjects with Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
15.RecruitingA Randomized Study to Evaluate FK962 in Subjects with Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
16.RecruitingTreatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug
Conditions: Hallucinations; Psychoses; Parkinson's Disease
17.Not yet recruitingStudy of Antidepressants in Parkinson’s Disease (SAD-PD)
Conditions: Parkinson Disease; Depression
18.RecruitingDepression in Alzheimer's Disease (DIADS-2)
Conditions: Alzheimer's Disease; Depression
19.RecruitingParkinson’s Research: The Organized Genetics Initiative (PROGENI)
Condition: Parkinson Disease
20.RecruitingA Pilot Therapeutic Trial Using Hydroxyurea in Type II and III Spinal Muscular Atrophy Patients
Condition: Spinal Muscular Atrophy
21.RecruitingA Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
22.RecruitingHuperzine A in Alzheimer's Disease
Condition: Alzheimer Disease
23.RecruitingEffects of ONO-2506PO in Patients with Alzheimer's Disease
Condition: Alzheimer's Disease
24.RecruitingSafety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer’s Disease
Condition: Alzheimer's Disease
25.RecruitingTranscranial Electrical Polarization to Treat Symptoms of Parkinson's Disease
Condition: Parkinson Disease
26.RecruitingMyotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Conditions: Myotonic Dystrophy; Muscular Dystrophy, Facioscapulohumeral; Muscular Dystrophy
27.RecruitingTiming of Voluntary Movement in Patients with Tourette Syndrome and Chronic Tic Disorder
Conditions: Tourette Syndrome; Tic Disorders
28.RecruitingPhase 1 Trial of Idebenone to Treat Patients with Friedreich's Ataxia
Condition: Friedreich Ataxia
29.RecruitingLevetiracetam Treatment of L-dopa Induced Dyskinesias
Conditions: Dyskinesias; Parkinson Disease
30.RecruitingCell Studies of Parkinson's Disease
Condition: Parkinson Disease
31.RecruitingAntigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
Condition: Alzheimer Disease
32.RecruitingALS Veterans Registry
Condition: ALS
33.RecruitingPirfenidone in Children and Young Adults with Neurofibromatosis type I and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis 1; Neurofibroma, Plexiform
34.RecruitingFamily Health After Predictive Huntington Disease (HD) Testing
Condition: Huntington Disease
35.RecruitingTreating Behavioral Disturbances in Individuals with Dementia
Conditions: Dementia; Alzheimer Disease
36.RecruitingValproate in Dementia (VALID)
Condition: Alzheimer Disease
37.RecruitingBrain Function in Primary Lateral Sclerosis
Condition: Motor Neuron Disease
38.RecruitingCreatine for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
39.RecruitingSAM-e for the Treatment of Depression in Patients with Parkinson's Disease
Conditions: Parkinson's Disease; Depression
40.RecruitingValerian to Improve Sleep in Patients with Parkinson's Disease
Conditions: Insomnia; Parkinson's Disease
41.Not yet recruitingDextromethorphan and Donepezil Hydrochloride for Rett Syndrome
Condition: Rett Syndrome
42.RecruitingStudy of Creatine Monohydrate in Patients with Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
43.RecruitingModafinil to Treat Fatigue in Post-Polio Syndrome
Condition: Postpoliomyelitis Syndrome
44.RecruitingAlzheimer's Disease: Therapeutic Potential of Estrogen
Condition: Alzheimer Disease
45.RecruitingCognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Condition: Alzheimer Disease
46.RecruitingHigh Intensity Light Therapy in Alzheimer's Disease
Conditions: Alzheimer's Disease; Dementia
47.RecruitingDelaying Alzheimer Disease Symptoms with Anti-Inflammatory Drugs
Conditions: Alzheimer Disease; Dementia
48.RecruitingAlzheimer's Disease Genetics Study
Conditions: Alzheimer Disease; Late Onset Alzheimer Disease
49.RecruitingStudying Automatic Movements in Patients with Parkinson's Disease
Condition: Parkinson Disease
50.RecruitingInvestigating the Safety of srTMS in the Treatment of Parkinson's Disease
Condition: Parkinson Disease

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act